ArticleNature reviews. Rheumatology2012

Clinical trials: Phase III trial results for tofacitinib bring new oral DMARD therapy a step closer for patients with rheumatoid arthritis.

Emma LeahPubMed ↗Publisher ↗

No numbers read from the abstract.